Wolfgang Albrecht

LBBW Asset Management Investmentgesellschaft mbH (LBBW Asset Management) is the wholly-owned investment management subsidiary of State-owned regional bank Landesbank Baden-Württemberg in Germany. The firm was founded in 2009 when LBBW Asset Management GmbH merged with fellow subsidiary Baden-Württembergische Investment GmbH. Headquartered in Stuttgart, LBBW Asset Management manages, administers and distributes mutual funds, institutional funds and funds of funds for institutional and retail clients. They also manage discretionary accounts.

UniCredit Bank AG (Broker) (UniCredit Bank-Broker) is the brokerage division of UniCredit Bank AG, a commercial bank headquartered in Munich, Germany. Formerly known as Bayerische Hypo- und Vereinsbank AG, the firm was founded in 1869 and is a subsidiary of UniCredit SpA (BIT: UCG) in Italy. UniCredit Bank-Broker is responsible for direct market access execution in listed products, as well as various kinds of brokerage services, such as OTC fund execution, care order execution, order and flow management for UniCredit Commercial Banks, subsidiaries, external clients and CIB internal desks.

R+V Versicherung AG (Investment Portfolio) (R+V Versicherung IP) is the investment portfolio division of R+V Versicherung AG, itself a subsidiary of DZ Bank AG in Germany. DZ Bank AG forms part of the cooperative financial network comprised of credit unions (Volksbanken and Raiffeisenbanken) for which they serve as the "central bank" and commercial bank. The firm was founded in 1994 when R+V Versicherung Holding merged with Rhen-Main Rückversicherungsgesellschaft AG and is headquartered in Wiesbaden. R+V Versicherung IP provides a range of insurance needs including automobile, liability and accident insurance to private and corporate customers. They offer their services in branches of the Volks- and Raiffeisen banks across Germany, and also sells through local representatives and agencies. They maintain close ties with German SMEs, typically in wholesaling and retailing, the skilled trades, the commercial sector and agriculture.

Franklin Templeton Investment Management Ltd. (Germany) (FTIML-Germany) is the German investment management division of Great Britain-based Franklin Templeton Investment Management Ltd., ultimately owned by Franklin Resources, Inc. (NYSE: BEN) in the US. Headquartered in Frankfurt, the firm was founded in 1992 and manages the Franklin Templeton Investments fund range for individuals, pension funds, trusts, local authorities, corporations, government bodies, fund of funds and multi-managers.

Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Landesbank Baden-Württemberg is a public bank providing all kinds of financial services to retail and corporate clients, savings banks, institutional clients and high net worth client. The company was founded on January 1, 1999 and is headquartered in Stuttgart, Germany.

Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA.

Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.

Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland.

Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020.

Tresides Asset Management GmbH (Tresides) is the asset management subsidiary of Südwestbank AG, itself a subsidiary of Santo Vermögensverwaltung GmbH in Germany.^ Established in 2013, the firm is based in Stuttgart and offers tailor-made investment solutions.

Deutsche Bank AG provides corporate banking and investment services. It offers asset and wealth management, corporate banking and securities and global transaction banking solutions. The company was founded in 1873 and is headquartered in London, the United Kingdom.

TRUMPF GmbH + Co. KG engages in the manufacture of machine tools, laser technology, and electronic products. The firm offers laser cutting machines, marking systems, bending machines, automation, storage systems, and punching machines. The company was founded in 1923 and is headquartered in Ditzingen, Germany.

Berthold Leibinger GmbH provides management services. The private company is based in Ditzingen, Germany. The German company was founded in 1960. The CEO is Oliver Maassen.

Novosom Verwaltungs GmbH provides clinical development services and hospital equipment. It offers its own euqipment and technology to discover new methods of healing and researching on ribonucleic acid. The company was founded by Steffen Panzner in 1999 and is headquartered in Halle, Germany.

coparion Komplementär GmbH (coparion) is an independent venture capital firm founded in 2015. The firm is headquartered in Cologne, Germany, with another German office located in Cologne.

LOCANIS AG specializes in the process optimization and goods tracking in warehouse logistics. Its products are site optimizer G40, G60, and GFLEX. In addition the firm offers mobile unit optimizers. The company was founded in 1985 and is headquartered in Unterföhring, Germany.

Neodigital Versicherung AG is a holding company, which provides online insurance solutions. It offers accident insurance, home insurance, personal liability insurance, as well as pet owner liability insurance. The company was founded by Dirk Wittling and Stephen Voss on December 27, 2016 and is headquartered in Neunkirchen, Germany.

Part of The Hearst Family Trust, Fitch Deutschland GmbH is a German company that provides investment research. The company is based in Frankfurt, Germany. Clemens Frech has been the CEO of the company since 2015.

B. Metzler seel. Sohn & Co. AG (Metzler Private Bank) is the private banking firm headquartered in Frankfurt, Germany. The firm was initially established as a trading house in 1674 by the Metzler family. Metzler Private Bank offers portfolio management, asset allocation and portfolio structuring controlling for entrepreneurs, entrepreneurial families, wealthy individuals and foundations in Germany.

Macquarie Capital Europe Ltd. (Germany) (MCE Germany) is the Germany-based brokerage division of Macquarie Capital Europe Ltd., which is ultimately held by Macquarie Group Ltd. (ASX: MQG). The firm is headquartered in Frankfurt, Germany and was founded in 2008. MCE Germany provides brokerage services to their clients.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany.

Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France.

AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom.

Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany.